Oxford's Covid vaccine trials in India will be over by January: Adar Poonawalla

Oxford's Covid vaccine trials in India will be over by January: Adar Poonawalla

India Today

Oxford and AstraZeneca's Covid-19 vaccine trails in India are expected to be over by January, said Serum Institute of India (SII) CEO Adar Poonawalla. Speaking to India Today TV, Poonawalla said that the vaccine trials in India will be completed by January, adding that the first dose has been given to most of the people who took part in the trial.

Sharing details of the final stage of trial for the Oxford-AstraZeneca's Covid-19 vaccine in India, Poonawalla said, "We have already given the first dose to most of the patients in the trial, which is more than a 1,000 already.

Disclaimer: This is an automatically aggregated article/story by a computer program and has not been created or edited by Newsdig.in.

World COVID19 Meter

65968237

Cases

45122391

Recovered

1519094

Deaths
Last updated: GMT
Advt
Advt
Advt
sitemap Disclaimer
Newsdig.in 2019